EGFR and non-small cell lung carcinoma: Notably, the cholesterol derivative 27‐hydroxycholesterol is enriched in NSCLC and exerts dual roles: activating liver X receptor signaling to suppress EGFR‐mutant cell proliferation, while also promoting bone metastasis and resistance via PI3K/STAT3 pathway activation [26].